Search

Your search keyword '"Selinger, Christina I."' showing total 141 results

Search Constraints

Start Over You searched for: Author "Selinger, Christina I." Remove constraint Author: "Selinger, Christina I."
141 results on '"Selinger, Christina I."'

Search Results

1. Data Set for Reporting Carcinoma of the Stomach in Gastrectomy: Recommendations From the International Collaboration on Cancer Reporting

2. Implementing structured pathology reporting protocol for non-melanocytic skin cancers: practical considerations

5. Biomarkers for ALK and ROS1 in Lung Cancer: Immunohistochemistry and Fluorescent In Situ Hybridization

9. Data Set for the Reporting of Endometrial Cancer: Recommendations From the International Collaboration on Cancer Reporting (ICCR)

10. Data Set for the Reporting of Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma: Recommendations From the International Collaboration on Cancer Reporting (ICCR)

11. Dataset for the Reporting of Carcinoma of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR)

15. Data Set for Reporting Carcinoma of the Stomach in Gastrectomy

23. Somatic mutations in salivary duct carcinoma and potential therapeutic targets

24. Screening for ROS1 gene rearrangements in non‐small‐cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target

25. Atypical Ewing sarcoma breakpoint region 1 fluorescencein-situhybridization signal patterns in bone and soft tissue tumours: diagnostic experience with 135 cases

26. BRAFV600EandNRASQ61L/Q61Rmutation analysis in metastatic melanoma using immunohistochemistry: a study of 754 cases highlighting potential pitfalls and guidelines for interpretation and reporting

28. Diagnostic and prognostic utility of MYB gene rearrangement detected by fluorescent in-situ hybridisation (FISH) in adenoid cystic carcinoma

29. Programmed death ligand 1 expression in triple‐negative breast cancer is associated with tumour‐infiltrating lymphocytes and improved outcome

31. PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma

32. A Detailed Clinicopathologic Study of ALK-translocated Papillary Thyroid Carcinoma

34. Atypical Ewing sarcoma breakpoint region 1 fluorescence in-situ hybridization signal patterns in bone and soft tissue tumours: diagnostic experience with 135 cases.

35. BRAFV600E and NRASQ61L/Q61R mutation analysis in metastatic melanoma using immunohistochemistry: a study of 754 cases highlighting potential pitfalls and guidelines for interpretation and reporting.

40. Loss of heterozygosity of the Mutated in Colorectal Cancer gene is not associated with promoter methylation in non-small cell lung cancer

41. Testing for anaplastic lymphoma kinase (ALK) rearrangement in lung adenocarcinomas: a multicentre study

45. Cell cycle marker expression in benign and malignant intraductal papillary lesions of the breast.

48. Reflex ALK immunohistochemistry is feasible and highly specific for ALK generearrangements in lung cancer

49. Testing for ALKrearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situhybridization

50. The “Mutated in Colorectal Cancer” Protein Is a Novel Target of the UV-Induced DNA Damage Checkpoint

Catalog

Books, media, physical & digital resources